Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
DENGUE WITH CENTRAL NERVOUS SYSTEM INVOLVEMENT.
StatXFinder: a web-based self-directed tool that provides appropriate statistical test selection for biomedical researchers in their scientific studies.
Expression of DNA methylation genes in secondary progressive multiple sclerosis.
Clemastine Enhances Myelination in the Prefrontal Cortex and Rescues Behavioral Changes in Socially Isolated Mice.
A novel synthetic compound MCAP suppresses LPS-induced murine microglial activation in vitro via inhibiting NF-kB and p38 MAPK pathways.
Age-dependent differences in microglial responses to systemic inflammation are evident as early as middle age.
Development and Pharmacological Characterization of Selective Blockers of 2-Arachidonoyl Glycerol Degradation with Efficacy in Rodent Models of Multiple Sclerosis and Pain.
Perception of Pain Self-efficacy and Fatigue in Greek Patients with Multiple Sclerosis: A Study Protocol.
Intrathecal gene therapy rescues a model of demyelinating peripheral neuropathy.
Clinical outcomes of sacral neuromodulation in patients with neurologic conditions.
Microglia play a major role in direct viral-induced demyelination.
Migraine Headaches And Pain With Neuropathic Characteristics: Comorbid Conditions In Patients With Multiple Sclerosis.
Teva to present further results of twenty-year open-label extension study of glatiramer acetate 20 mg daily for relapsing-remitting multiple sclerosis
Immunology and Oxidative Stress in Multiple Sclerosis: Clinical and Basic Approach.
Towards patient collaboration in cognitive assessment: Specificity, sensitivity, and incremental validity of self-report.
Benefits versus risks of latest therapies in multiple sclerosis: a perspective review.
Partial suppression of M1 microglia by Janus kinase 2 inhibitor does not protect against neurodegeneration in animal models of amyotrophic lateral sclerosis.
Acthar gel treatment suppresses acute exacerbations in a murine model of relapsing-remitting multiple sclerosis.
A modality-agnostic patch-based technique for lesion filling in multiple sclerosis.
The association between multiple sclerosis and fracture risk.
Application of next-generation sequencing technologies in Neurology.
Promoting Physical Activity through a Manual Wheelchair Propulsion Intervention in Persons with Multiple Sclerosis.
[Foix-Chavany-Marie syndrome presenting as multiple sclerosis].
Predicting medication adherence in multiple sclerosis using telephone-based home monitoring.
Pseudoneoplasms in the nervous system.
Pages
« first
‹ previous
…
594
595
596
597
598
599
600
601
602
…
next ›
last »